APC
TDOC icon

Aspire Private Capital’s Teladoc Health TDOC Stock Holding History

Aspire Private Capital’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5
Closed -$46 – 577
2024
Q3 		$46 Hold
5
– – ﹤0.01% 667
2024
Q2 		$49 Hold
5
– – ﹤0.01% 680
2024
Q1 		$76 Hold
5
– – ﹤0.01% 705
2023
Q4 		$107 Hold
5
– – ﹤0.01% 684
2023
Q3 		$92 Hold
5
– – ﹤0.01% 686
2023
Q2 		$127 Hold
5
– – ﹤0.01% 655
2023
Q1 		$130 Hold
5
– – ﹤0.01% 639
2022
Q4 		$118 Sell
5
-5
-50% -$135 ﹤0.01% 637
2022
Q3 		$0 Hold
10
– – ﹤0.01% 658
2022
Q2 		$0 Hold
10
– – ﹤0.01% 641
2022
Q1 		$1K Hold
10
– – ﹤0.01% 567
2021
Q4 		$1K Buy
10
+9
+900% +$1.08K ﹤0.01% 604
2021
Q3 		$0 Hold
1
– – ﹤0.01% 636
2021
Q2 		$0 Buy
+1
New +$162 ﹤0.01% 630

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $5.1B AUM 214.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Aspire Private Capital's TDOC Position: Q4 2024 in Review

Aspire Private Capital sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 5 shares — an estimated $46 sold.

Aspire Private Capital first reported a position in TDOC in Q2 2021 and held it in 14 quarters. The position peaked at $1K in Q1 2022. 381 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

  • Aspire Private Capital reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
  • Aspire Private Capital sold 5 Teladoc Health shares in Q4 2024, an estimated $46.
  • Aspire Private Capital first reported a position in Teladoc Health in Q2 2021 and held it in 14 quarters.
  • Aspire Private Capital's Teladoc Health position peaked at $1K in Q1 2022.
  • 381 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.